Never miss an important update

Click    to get notified about important updates only.   

99 push-notification-bg

99 Alternatives

We are sorry that you have opted out.

However, if you accidentally selected "Block" or you want to receive notifications in the future, then follow any of the following instructions.

Option 1

99 chrome-b-n

Option 2

1. visit to Chrome > Settings > Content Settings

2. click here Content Settings > Notifications > Manage Exceptions

OR

Copy & Paste in Addrsss Bar > "chrome://settings/content/notifications?search=notif"

3. Select Allow for https://www.99alternatives.com/

4. Refresh the page.

99 Alternatives

Opportunities are Infinite

Please wait
99 Alternative logo
Business
All Categories

Investors Space-Spreading Awareness

Join a community that's informative, communicative & Interactive

99 Alternatives-Taking Initiative

99 top-hearder-guide-book
Register Today to Download Your Free
Alternative Asset Guide for 2020
Worth £49.99 and Free Life Time
Subscription to 99 Alternatives Web Portal
Worth £100's Limited Availability…
register for e Asset Guide
Latest News
Preliminary agreement reached in Lufthansa bailout row - sources
Saudi Arabia's PIF gets $40 billion from foreign reserves to fund overseas investments
Preliminary agreement reached in Lufthansa bailout row - source
Stocks rebound on relief at Trump's response to China over Hong Kong
Trump administration to study ways to protect for U.S. investors from Chinese firms
U.S. senators urge probe of TikTok on children's privacy
Scam Alerts
What Is The Computer Misuse Act?
Call Centre Scams Conning People
The easy way to stop your online accounts getting hacked
Fraudster sentenced after funding luxury holidays through £50k smishing scam
Banking industry stops £4.5 million of fraud a day in first half of 2019
Barclays issues warning to university students, as number of under-21s recruited as money mules..
Interact-With-Prospective-Clients_728x9099 Ads

India's Jubilant signs licensing deal for Gilead's COVID-19 drug

FILE PHOTO: Gilead Sciences Inc pharmaceutical company is seen during the outbreak of the
Share:
(Reuters) - India's Jubilant Life Sciences Ltd said on Tuesday it had signed a non-exclusive licensing agreement for selling Gilead Sciences Inc's experimental COVID-19 treatment remdesivir in 127 countries, including India.The drug earlier this month received the U.S. Food and Drug Administration's emergency use authorization to treat COVID-19 patients.Jubilant also gets the rights to..
Date Published: May 12, 2020
To view the full article, Register Now.
Register Today And Get Your Free Lifetime Elite Subscription Worth £100’s
Are You Already a Member? Login
728x9099 Ads

Related Articles

300x25099 Ads

Video

Copyright © 2020 99alternatives Ltd.   All rights reserved.

Designed and Managed by Mont Digital